Daily as of 3 Nov 16:00 ET
- Price
- below both $1.46 vs 50 $1.85 / 200 $1.89
- Projection
- No cross projected
- Test
- Cross test window open, no test bar yet
- Last cross
- 💀Death cross 2 Nov 2026 · projected 29 bars out
LXRX | Lexicon PharmaceuticalsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$1.46
+$0.02 (+1.39%)
Lexicon Pharmaceuticals (LXRX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.
The 50 SMA has sat below the 200 on the daily since Nov 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- below both $1.42 vs 50 $1.78 / 200 $1.62
- Projection
- 💀Death cross estimated 15+ weeks out
- Test
- No active test
- Last cross
- 🟨Golden cross week of 3 Aug 2026 · projected 25 bars out · tested 1 bar
4-hour as of 3 Nov 13:30 ET
- Price
- below both $1.47 vs 50 $1.61 / 200 $2.07
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 23 Sep 2026 · projected 29 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 2 Nov 2026 | 💀Death steep | daily | 29 bars out | Active Cross Test |
| 23 Sep 2026 | 💀Death | 4-hour | 29 bars out | Not tested |
| week of 3 Aug 2026 | 🟨Golden moderate | weekly | 25 bars out | 1 bar cross test |
| 17 Feb 2026 | 🟨Golden | 4-hour | 9 bars out | 2 bar cross test |
| 31 Dec 2025 | 💀Death | 4-hour | 27 bars out | Not tested |
About LXRX
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$4.3M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandsmall